Figure 3.

The impact of TIGIT expression on NK cell cytotoxicity in CBF-AML patients and HDs. PFP⁺ cells% in total NK cells (a), GZMB⁺ cells% in total NK cells (b), PFP⁺ cells% and GZMB⁺ cells% in pairing of TIGIT⁺ to TIGIT⁻ cells in total NK cells of individual cases (c), PFP⁺ cells% and GZMB⁺ cells% ratios of TIGIT⁺/TIGIT⁻ NK cells (d), PFP⁺ cells% in CD56^dim NK cells (e), GZMB⁺ cells% in CD56^dim NK cells (f), PFP⁺ cells% and GZMB+ cells% in pairing of TIGIT⁺ to TIGIT⁻ cells in CD56^dim NK cells of individual cases (g), and PFP⁺ cells% and GZMB⁺ cells% ratios of TIGIT⁺/TIGIT⁻ CD56^dim NK cells (h). Numbers in this figure refer to the p values.